August 10, 2026
How this plays out
Now that all the pump companies have reported results it’s time to look how the rest of 2026 will play out and what’s in store for 2027.
Insulet YTD stock performance -50.33%
With numerous competitors coming later this year Insulet’s main goal is to regain investor confidence while building their installed base.
Tandem YTD stock performance +1.82%
Set the table for Tobi while continuing their transition to pay as go.
Beta Bionics YTD stock performance -47.02%
Battle to increase the installed base while getting the Mint ready for FDA submission.
MiniMed YTD stock performance . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
